Genomic screening in children: BabyScreen+

Gene: MEN1

Green List (high evidence)

MEN1 (menin 1, Ensemblv90)
EnsemblGeneIds (GRCh38): ENSG00000133895
EnsemblGeneIds (GRCh37): ENSG00000133895
OMIM: 613733, ClinGen, DECIPHER
MEN1 is in 1 panel

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Rated as 'strong actionability' in paediatric patients by ClinGen.

Parathyroid tumors, which cause PHPT, are the most common feature and the first clinical manifestation in 90% of individuals with MEN1 with onset typically between ages 20 and 25 years. Almost all (95-100%) individuals with MEN1 can expect to have PHPT by age 50 years. However, MEN1 affects all age groups, with a reported age range of 5 to 81 years; 17% of MEN1 tumors are diagnosed under age 21. Untreated patients with MEN1 have a decreased life expectancy with a 50% probability of death by age 50. The cause of death in 50-70% of cases is due to a malignant tumor process or sequelae of the disease, with malignancies accounting for 30% of all deaths.

Surveillance generally recommended 5yo onwards.
Sources: Expert Review
Created: 14 Aug 2025, 3:34 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Multiple endocrine neoplasia 1, MIM#131100

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Expert Review
Phenotypes
  • Multiple endocrine neoplasia 1, MIM#131100
Tags
cancer treatable
OMIM
613733
ClinGen
MEN1
DECIPHER
MEN1
Clinvar variants
Variants in MEN1
Penetrance
None
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
14 Aug 2025, Gel status: 3

Added Tag, Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag cancer tag was added to gene: MEN1. Tag treatable tag was added to gene: MEN1.

14 Aug 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: men1 has been classified as Green List (High Evidence).

14 Aug 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: men1 has been classified as Green List (High Evidence).

14 Aug 2025, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: MEN1 was added gene: MEN1 was added to Genomic screening in children: BabyScreen+. Sources: Expert Review Mode of inheritance for gene: MEN1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: MEN1 were set to Multiple endocrine neoplasia 1, MIM#131100 Review for gene: MEN1 was set to GREEN